Grand Challenges in global eye health: a global prioritisation process using Delphi method
- PMID: 35028632
- PMCID: PMC8732284
- DOI: 10.1016/S2666-7568(21)00302-0
Grand Challenges in global eye health: a global prioritisation process using Delphi method
Abstract
Background: We undertook a Grand Challenges in Global Eye Health prioritisation exercise to identify the key issues that must be addressed to improve eye health in the context of an ageing population, to eliminate persistent inequities in health-care access, and to mitigate widespread resource limitations.
Methods: Drawing on methods used in previous Grand Challenges studies, we used a multi-step recruitment strategy to assemble a diverse panel of individuals from a range of disciplines relevant to global eye health from all regions globally to participate in a three-round, online, Delphi-like, prioritisation process to nominate and rank challenges in global eye health. Through this process, we developed both global and regional priority lists.
Findings: Between Sept 1 and Dec 12, 2019, 470 individuals complete round 1 of the process, of whom 336 completed all three rounds (round 2 between Feb 26 and March 18, 2020, and round 3 between April 2 and April 25, 2020) 156 (46%) of 336 were women, 180 (54%) were men. The proportion of participants who worked in each region ranged from 104 (31%) in sub-Saharan Africa to 21 (6%) in central Europe, eastern Europe, and in central Asia. Of 85 unique challenges identified after round 1, 16 challenges were prioritised at the global level; six focused on detection and treatment of conditions (cataract, refractive error, glaucoma, diabetic retinopathy, services for children and screening for early detection), two focused on addressing shortages in human resource capacity, five on other health service and policy factors (including strengthening policies, integration, health information systems, and budget allocation), and three on improving access to care and promoting equity.
Interpretation: This list of Grand Challenges serves as a starting point for immediate action by funders to guide investment in research and innovation in eye health. It challenges researchers, clinicians, and policy makers to build collaborations to address specific challenges.
Funding: The Queen Elizabeth Diamond Jubilee Trust, Moorfields Eye Charity, National Institute for Health Research Moorfields Biomedical Research Centre, Wellcome Trust, Sightsavers, The Fred Hollows Foundation, The Seva Foundation, British Council for the Prevention of Blindness, and Christian Blind Mission.
Translations: For the French, Spanish, Chinese, Portuguese, Arabic and Persian translations of the abstract see Supplementary Materials section.
© 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Conflict of interest statement
MJB reports grants (in support of the work of the Lancet Global Health Commission) from The Wellcome Trust, The Queen Elizabeth Diamond Jubilee Trust, Sightsavers, The Fred Hollows Foundation, The British Council for the Prevention of Blindness, Moorfields Eye Charity, The Seva Foundation, and Christian Blind Mission during the conduct of the study. NC reports personal fees from Belkin Vision. DSF reports personal fees from W L Gore, Bausch and Lomb, Life Biosciences, Thea, and iDx outside of the submitted work; and is a member of the Board of Orbis International. TYW reports grants from Allergan, Bayer, Boehringer Ingelheim, Eden Ophthalmic, Genentech, Iveric Bio, Merck, Novartis, Oxurion (formerly ThromboGenics), Roche, Samsung, Shanghai Henlius, Zhaoke Pharmaceutical, and Aldropika Therapeutics, and is co-founder of start-up companies Plano and EyRiS. PTK reports stockholding for Radiance Therapeutics and Optceutics; personal fees from Aerie, Alcon, AstraZeneca, Bausch + Lomb, Genetech, Novartis, Pfizer, and Sanofi-Aventis outside of the submitted work; being a board member of Moorfields Eye Hospital; and having a patent pending for Biochannel Device. HT reports leadership roles for the International Council of Ophthalmology and the Ophthalmology Foundation (unpaid roles). SKW reports board membership (unpaid) of Christian Blind Mission-USA. All other authors declare no competing interests.
Figures
Comment in
-
Barriers to eye care for older people in the Philippines.Lancet Healthy Longev. 2022 Mar;3(3):e130. doi: 10.1016/S2666-7568(22)00025-3. Lancet Healthy Longev. 2022. PMID: 36098287 No abstract available.
Similar articles
-
Global economic productivity losses from vision impairment and blindness.EClinicalMedicine. 2021 Apr 26;35:100852. doi: 10.1016/j.eclinm.2021.100852. eCollection 2021 May. EClinicalMedicine. 2021. PMID: 33997744 Free PMC article.
-
Association between vision impairment and mortality: a systematic review and meta-analysis.Lancet Glob Health. 2021 Apr;9(4):e418-e430. doi: 10.1016/S2214-109X(20)30549-0. Epub 2021 Feb 16. Lancet Glob Health. 2021. PMID: 33607015 Free PMC article.
-
Strategies to address inequity of uncorrected refractive error in the Western Pacific: A modified Delphi process.Ophthalmic Physiol Opt. 2024 Sep;44(6):1148-1161. doi: 10.1111/opo.13348. Epub 2024 Jun 16. Ophthalmic Physiol Opt. 2024. PMID: 38881170
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study.Lancet Glob Health. 2021 Feb;9(2):e144-e160. doi: 10.1016/S2214-109X(20)30489-7. Epub 2020 Dec 1. Lancet Glob Health. 2021. PMID: 33275949 Free PMC article.
Cited by
-
The Rapid Assessment of Avoidable Blindness survey: Review of the methodology and protocol for the seventh version (RAAB7).Wellcome Open Res. 2024 Mar 8;9:133. doi: 10.12688/wellcomeopenres.20907.1. eCollection 2024. Wellcome Open Res. 2024. PMID: 38828387 Free PMC article.
-
Eye health: what research is needed, and where?Community Eye Health. 2022;35(117):13. Epub 2023 Jan 30. Community Eye Health. 2022. PMID: 37007827 Free PMC article.
-
Global estimates on the number of people blind or visually impaired by Uncorrected Refractive Error: a meta-analysis from 2000 to 2020.Eye (Lond). 2024 Aug;38(11):2083-2101. doi: 10.1038/s41433-024-03106-0. Epub 2024 Jul 4. Eye (Lond). 2024. PMID: 38965322 Free PMC article.
-
Research about eye health and eye health services in Pacific Island Countries and Territories: a scoping review.Lancet Reg Health West Pac. 2024 Jul 27;50:101152. doi: 10.1016/j.lanwpc.2024.101152. eCollection 2024 Sep. Lancet Reg Health West Pac. 2024. PMID: 39161741 Free PMC article.
-
Uptake of eye care services in South India: Retrospective mapping of self-reported barriers using the Theoretical Domains Framework.Ophthalmic Physiol Opt. 2025 Mar;45(2):450-457. doi: 10.1111/opo.13424. Epub 2024 Nov 27. Ophthalmic Physiol Opt. 2025. PMID: 39602082 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous